Partner news 23 January 2020 BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders Read full story
Partner news 13 January 2020 Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen Read full story
Partner news 13 January 2020 Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO) Read full story
